What is TAE Technologies doing with its multi-state site evaluation visits?

TAE Technologies commenced multi-state site visits across the United States on March 26, 2026, as part of its siting and development process for its first fusion power plant. The visits are designed to identify locations capable of supporting the development, construction and long-term operation of TAE's initial 50 MWe fusion facility and future utility-scale deployments. TAE's leadership delegation — including CEO Michl Binderbauer, CFO Cedric Burgher, and TAE Global GmbH CEO Jonathan Toretta — is meeting local stakeholders and assessing site-specific infrastructure conditions at each location across the United States.

What site selection criteria is TAE evaluating across candidate locations?

TAE's published site selection criteria include a minimum of 20 acres — sufficient to accommodate the initial 50 MWe reactor, a future 350–500 MWe facility, and a next-generation advanced research reactor on the same site. Additional criteria include access to a primary distribution grid capable of transporting adequate electricity to and from the plant, proximity to a metropolitan hub, airport, and pool of local skilled labour, the presence of local and state governments that are supportive of energy production and fusion power, and the ability to maintain sufficient security for an industrial energy facility. TAE is also assessing alignment of power demand and grid capacity in each region.

What is the TAE Technologies and Trump Media merger and how does it fund the power plant programme?

TAE Technologies and Trump Media and Technology Group (TMTG) — the publicly traded company behind Truth Social — announced a definitive all-stock merger agreement on December 18, 2025, valued at more than $6 billion. Under the terms, shareholders of each company will own approximately 50% of the combined entity on a fully diluted basis. TMTG has already transferred $200 million in cash to TAE under the terms of the merger agreement, with an additional $100 million available upon TAE's filing of a Form S-4 registration statement with the SEC. The transaction is expected to close in mid-2026, subject to shareholder and regulatory approvals. Upon closing, Michl Binderbauer and TMTG's Devin Nunes will serve as co-CEOs, and Michael B. Schwab is expected to chair a nine-member board.

What is TAE's track record and technical foundation ahead of this commercial deployment?

TAE Technologies was founded in 1998 and has spent more than 25 years developing its beam-driven field-reversed configuration (FRC) fusion approach. The company has built and safely operated five fusion reactors across its device generations — from early proof-of-concept machines through to its current Norm device — and holds over 1,600 granted patents globally. TAE employs more than 400 staff including 62 PhD holders. Prior to the TMTG merger, the company raised more than $1.3 billion in private capital from investors including Google, Chevron Technology Ventures, Goldman Sachs, and Sumitomo Corporation of Americas.

What fusion technology will TAE's power plant use and how does it differ from tokamaks?

TAE's commercial power plant will use its advanced beam-driven field-reversed configuration (FRC) — a compact magnetic confinement approach that creates its own internal magnetic field through neutral beam injection, without needing a large external magnetic coil array or a central solenoid. TAE's 2025 breakthrough with the Norm device demonstrated that NBI-only FRC formation can eliminate the complex theta-pinch formation hardware previously required, reducing reactor size and hardware by up to 50% compared to prior FRC machines. TAE's target fuel is hydrogen-boron — an aneutronic reaction that produces no radioactive waste — though the first commercial plant may operate on a deuterium-based fuel cycle during the initial demonstration phase.

Why is site selection now as strategically important as plasma physics milestones for commercial fusion?

As private fusion companies move from laboratory proof-of-concept to deployment-grade infrastructure decisions, factors like grid connectivity, land availability, permitting jurisdiction, skilled labour pools, and local government support are becoming gating constraints on commercial timelines that are as consequential as plasma physics performance. A reactor that achieves scientific breakeven but cannot obtain site permits, grid interconnection agreements, or construction workforce within its funding runway will still fail to deliver power. TAE's decision to begin physical site visits — with C-suite leadership on the ground — signals that deployment logistics, stakeholder alignment, and infrastructure due diligence are now running in parallel with the physics and engineering programme rather than being deferred to after technical milestones are achieved.

What are the precise financial terms of the TAE-TMTG merger transaction, the capital deployment timeline, and the governance structure of the combined company?

The TAE-TMTG merger is structured as an all-stock transaction valued at more than $6 billion, based on TMTG's trailing 30-day volume-weighted average price as of December 17, 2025 — implying a per-share value for TAE common stock of $53.89 on a fully diluted basis. Each company's shareholders will own approximately 50% of the combined entity at closing. Capital has been deployed in two tranches under a convertible promissory note: $200 million was transferred to TAE at signing, with an additional $100 million available upon TAE's filing of the Form S-4 registration statement with the SEC. The Form S-4, when filed, will contain the proxy statement/prospectus required for the TMTG shareholder vote. The combined company will be structured with TMTG as the holding company, encompassing Truth Social, Truth+, Truth.Fi, TAE Technologies, TAE Power Solutions, and TAE Life Sciences. Binderbauer and Nunes will serve as co-CEOs post-closing, with Michael B. Schwab — founder and managing director of Big Sky Partners, a TAE investor of two decades — expected to chair the nine-member board.

How does TAE's 50 MWe first plant positioning compare to CFS's ARC, Helion's commercial plant, and Commonwealth Fusion's grid connection timeline, and what regulatory pathway does a beam-driven FRC facility require that differs from tokamak-based competitors?

Among private fusion companies targeting early 2030s grid connection, TAE's 50 MWe first plant is the smallest and earliest-stage commercial offering — functioning more as a large-scale demonstration of commercial operation than a utility-scale baseload generator. CFS's ARC is specified at 400 MWe in Chesterfield County, Virginia, with an Eni power purchase agreement exceeding $1 billion and a Google 200 MW PPA. Helion targets a 50 MW first plant in Washington State under its Microsoft PPA for 2028. TAE's 50 MWe scale is comparable to Helion's initial commitment but differs in fuel cycle: TAE's hydrogen-boron FRC targets aneutronic operation that would substantially reduce radiation shielding, activated waste classification, and tritium handling requirements relative to deuterium-tritium tokamaks. This has regulatory licensing implications: an aneutronic FRC facility producing minimal neutron flux and no tritium breeding requirement may qualify for a significantly simpler NRC licensing framework than DT tokamaks — which are currently navigating complex novel regulatory pathways for tritium handling and activated structural materials. The 20-acre minimum site footprint TAE has published is also notably smaller than the industrial campus scales implied by 400 MWe tokamak plants with tritium processing infrastructure, potentially widening the range of viable site locations. The primary commercial risk is that TAE's Da Vinci power plant design has not yet been built or demonstrated at any scale — the Norm device validates the NBI-only FRC formation physics but not the full power plant systems integration, blanket, or energy conversion architecture required for the 50 MWe commercial plant.

What does the TMTG merger mean for TAE's access to public capital markets, and how does the combined company's dual mission — fusion energy and Truth Social — affect the investment thesis and balance sheet risk profile for institutional investors assessing the fusion sector?

The TAE-TMTG merger creates what would be one of the first publicly traded fusion companies, giving TAE access to public equity capital markets that have previously been unavailable to private fusion developers. TMTG reported total financial assets of $3.1 billion as of Q3 2025, including cash, short-term investments, and digital assets accumulated since its March 2024 public listing. For institutional investors assessing the fusion sector, the merger creates a structurally unusual vehicle: a single listed entity whose valuation is simultaneously exposed to Truth Social's social media revenue trajectory, TAE's fusion development timeline, TAE Power Solutions' EV power management business, and TAE Life Sciences' Boron Neutron Capture Therapy platform. This conglomerate structure means the fusion programme's capital access is partially a function of Truth Social's stock performance — a dependency that is absent for privately held competitors like CFS (nearly $3 billion raised from dedicated fusion/energy investors) and Helion (backed by Open Philanthropy and Sam Altman). For fusion-sector analysts, the $6 billion merger valuation implies a premium relative to TAE's most recent private fundraising rounds, but the as-yet-unbuilt Da Vinci power plant means this valuation is largely based on the NBI-only FRC breakthrough, the patent estate, and the site programme's implied progress toward construction — rather than on contracted revenue, a completed demonstration reactor, or an approved NRC licence. The Form S-4, when filed, will provide the first public disclosure of TAE's detailed financial statements and will be the primary document against which institutional investors can assess the merger's valuation basis.

What is TAE Technologies doing with its multi-state site evaluation visits?

TAE Technologies commenced multi-state site visits across the United States on March 26, 2026, as part of its siting and development process for its first fusion power plant. The visits are designed to identify locations capable of supporting the development, construction and long-term operation of TAE's initial 50 MWe fusion facility and future utility-scale deployments. TAE's leadership delegation — including CEO Michl Binderbauer, CFO Cedric Burgher, and TAE Global GmbH CEO Jonathan Toretta — is meeting local stakeholders and assessing site-specific infrastructure conditions at each location across the United States.

What site selection criteria is TAE evaluating across candidate locations?

TAE's published site selection criteria include a minimum of 20 acres — sufficient to accommodate the initial 50 MWe reactor, a future 350–500 MWe facility, and a next-generation advanced research reactor on the same site. Additional criteria include access to a primary distribution grid capable of transporting adequate electricity to and from the plant, proximity to a metropolitan hub, airport, and pool of local skilled labour, the presence of local and state governments that are supportive of energy production and fusion power, and the ability to maintain sufficient security for an industrial energy facility. TAE is also assessing alignment of power demand and grid capacity in each region.

What is the TAE Technologies and Trump Media merger and how does it fund the power plant programme?

TAE Technologies and Trump Media and Technology Group (TMTG) — the publicly traded company behind Truth Social — announced a definitive all-stock merger agreement on December 18, 2025, valued at more than $6 billion. Under the terms, shareholders of each company will own approximately 50% of the combined entity on a fully diluted basis. TMTG has already transferred $200 million in cash to TAE under the terms of the merger agreement, with an additional $100 million available upon TAE's filing of a Form S-4 registration statement with the SEC. The transaction is expected to close in mid-2026, subject to shareholder and regulatory approvals. Upon closing, Michl Binderbauer and TMTG's Devin Nunes will serve as co-CEOs, and Michael B. Schwab is expected to chair a nine-member board.

What is TAE's track record and technical foundation ahead of this commercial deployment?

TAE Technologies was founded in 1998 and has spent more than 25 years developing its beam-driven field-reversed configuration (FRC) fusion approach. The company has built and safely operated five fusion reactors across its device generations — from early proof-of-concept machines through to its current Norm device — and holds over 1,600 granted patents globally. TAE employs more than 400 staff including 62 PhD holders. Prior to the TMTG merger, the company raised more than $1.3 billion in private capital from investors including Google, Chevron Technology Ventures, Goldman Sachs, and Sumitomo Corporation of Americas.

What fusion technology will TAE's power plant use and how does it differ from tokamaks?

TAE's commercial power plant will use its advanced beam-driven field-reversed configuration (FRC) — a compact magnetic confinement approach that creates its own internal magnetic field through neutral beam injection, without needing a large external magnetic coil array or a central solenoid. TAE's 2025 breakthrough with the Norm device demonstrated that NBI-only FRC formation can eliminate the complex theta-pinch formation hardware previously required, reducing reactor size and hardware by up to 50% compared to prior FRC machines. TAE's target fuel is hydrogen-boron — an aneutronic reaction that produces no radioactive waste — though the first commercial plant may operate on a deuterium-based fuel cycle during the initial demonstration phase.

Why is site selection now as strategically important as plasma physics milestones for commercial fusion?

As private fusion companies move from laboratory proof-of-concept to deployment-grade infrastructure decisions, factors like grid connectivity, land availability, permitting jurisdiction, skilled labour pools, and local government support are becoming gating constraints on commercial timelines that are as consequential as plasma physics performance. A reactor that achieves scientific breakeven but cannot obtain site permits, grid interconnection agreements, or construction workforce within its funding runway will still fail to deliver power. TAE's decision to begin physical site visits — with C-suite leadership on the ground — signals that deployment logistics, stakeholder alignment, and infrastructure due diligence are now running in parallel with the physics and engineering programme rather than being deferred to after technical milestones are achieved.

What are the precise financial terms of the TAE-TMTG merger transaction, the capital deployment timeline, and the governance structure of the combined company?

The TAE-TMTG merger is structured as an all-stock transaction valued at more than $6 billion, based on TMTG's trailing 30-day volume-weighted average price as of December 17, 2025 — implying a per-share value for TAE common stock of $53.89 on a fully diluted basis. Each company's shareholders will own approximately 50% of the combined entity at closing. Capital has been deployed in two tranches under a convertible promissory note: $200 million was transferred to TAE at signing, with an additional $100 million available upon TAE's filing of the Form S-4 registration statement with the SEC. The Form S-4, when filed, will contain the proxy statement/prospectus required for the TMTG shareholder vote. The combined company will be structured with TMTG as the holding company, encompassing Truth Social, Truth+, Truth.Fi, TAE Technologies, TAE Power Solutions, and TAE Life Sciences. Binderbauer and Nunes will serve as co-CEOs post-closing, with Michael B. Schwab — founder and managing director of Big Sky Partners, a TAE investor of two decades — expected to chair the nine-member board.

How does TAE's 50 MWe first plant positioning compare to CFS's ARC, Helion's commercial plant, and Commonwealth Fusion's grid connection timeline, and what regulatory pathway does a beam-driven FRC facility require that differs from tokamak-based competitors?

Among private fusion companies targeting early 2030s grid connection, TAE's 50 MWe first plant is the smallest and earliest-stage commercial offering — functioning more as a large-scale demonstration of commercial operation than a utility-scale baseload generator. CFS's ARC is specified at 400 MWe in Chesterfield County, Virginia, with an Eni power purchase agreement exceeding $1 billion and a Google 200 MW PPA. Helion targets a 50 MW first plant in Washington State under its Microsoft PPA for 2028. TAE's 50 MWe scale is comparable to Helion's initial commitment but differs in fuel cycle: TAE's hydrogen-boron FRC targets aneutronic operation that would substantially reduce radiation shielding, activated waste classification, and tritium handling requirements relative to deuterium-tritium tokamaks. This has regulatory licensing implications: an aneutronic FRC facility producing minimal neutron flux and no tritium breeding requirement may qualify for a significantly simpler NRC licensing framework than DT tokamaks — which are currently navigating complex novel regulatory pathways for tritium handling and activated structural materials. The 20-acre minimum site footprint TAE has published is also notably smaller than the industrial campus scales implied by 400 MWe tokamak plants with tritium processing infrastructure, potentially widening the range of viable site locations. The primary commercial risk is that TAE's Da Vinci power plant design has not yet been built or demonstrated at any scale — the Norm device validates the NBI-only FRC formation physics but not the full power plant systems integration, blanket, or energy conversion architecture required for the 50 MWe commercial plant.

What does the TMTG merger mean for TAE's access to public capital markets, and how does the combined company's dual mission — fusion energy and Truth Social — affect the investment thesis and balance sheet risk profile for institutional investors assessing the fusion sector?

The TAE-TMTG merger creates what would be one of the first publicly traded fusion companies, giving TAE access to public equity capital markets that have previously been unavailable to private fusion developers. TMTG reported total financial assets of $3.1 billion as of Q3 2025, including cash, short-term investments, and digital assets accumulated since its March 2024 public listing. For institutional investors assessing the fusion sector, the merger creates a structurally unusual vehicle: a single listed entity whose valuation is simultaneously exposed to Truth Social's social media revenue trajectory, TAE's fusion development timeline, TAE Power Solutions' EV power management business, and TAE Life Sciences' Boron Neutron Capture Therapy platform. This conglomerate structure means the fusion programme's capital access is partially a function of Truth Social's stock performance — a dependency that is absent for privately held competitors like CFS (nearly $3 billion raised from dedicated fusion/energy investors) and Helion (backed by Open Philanthropy and Sam Altman). For fusion-sector analysts, the $6 billion merger valuation implies a premium relative to TAE's most recent private fundraising rounds, but the as-yet-unbuilt Da Vinci power plant means this valuation is largely based on the NBI-only FRC breakthrough, the patent estate, and the site programme's implied progress toward construction — rather than on contracted revenue, a completed demonstration reactor, or an approved NRC licence. The Form S-4, when filed, will provide the first public disclosure of TAE's detailed financial statements and will be the primary document against which institutional investors can assess the merger's valuation basis.

TAE Technologies begins U.S. site selection for first 50 MWe fusion power plant targeted for early 2030s

Q: What size is TAE's first fusion power plant and when is it targeted for grid delivery?

TAE's first fusion power plant is targeted at approximately 50 megawatts electric (MWe), with grid delivery aimed at the early 2030s. The 50 MWe plant is the first step in TAE's commercial deployment programme — future TAE fusion power plants are expected to range from 350 to 500 MWe, reflecting the company's longer-term goal of delivering utility-scale fusion energy to the grid and to carbon-intensive industrial processes. The combined TAE-TMTG company plans to site and begin construction in 2026, subject to merger approvals and regulatory requirements.

Category: Magnets, Simulations, Vessels

April 1, 2026

TAE Technologies fusion reactor cutaway model showing internal plasma confinement chamber, superconducting coil assemblies and field-reversed configuration components, as the company advances U.S. site evaluation for its first 50 MWe fusion power plant.

TAE Technologies’ 25-year fusion journey – from five safely operated reactors to siting America’s first 50 MWe utility-scale power plant

(Image courtesy of TAE Technologies)

TAE Technologies has launched multi-state site evaluation visits across the United States, moving decisively toward construction of its first fusion power plant – a 50 MWe facility targeting grid delivery in the early 2030s. Backed by a $6 billion merger with Trump Media and Technology Group and more than 25 years of reactor development, the company is now translating laboratory credibility into deployment-grade infrastructure decisions that will define its commercial trajectory.

What TAE Is evaluating

The visits form part of a broader effort to identify locations capable of supporting the development, construction and long-term operation of TAE’s first 50 MWe fusion facility, as well as future utility-scale plants. TAE is assessing land access, connectivity to primary distribution grids, proximity to skilled labour and transportation infrastructure, and alignment with local and state stakeholders at each candidate site.

The regions under consideration reflect areas where power demand, industrial infrastructure and grid capacity converge. Those are, according to TAE, the conditions essential to reliable utility-scale generation and the longer-term expansion the company is planning. The combined company plans to site and begin construction in 2026, subject to merger approvals, ahead of early 2030s generation.

The leadership team on the ground

TAE’s delegation includes CEO Michl Binderbauer, CFO Cedric Burgher and TAE Global GmbH CEO Jonathan Toretta, alongside senior engineering and finance leaders. Together, they are meeting local stakeholders and assessing site-specific conditions at each location.

Binderbauer was direct about the company’s priorities. “We are evaluating locations based on the infrastructure, grid connectivity and long-term development conditions required to support reliable power generation,” he said. “This process is about ensuring we build in the right place, with the right partners, to support sustained deployment in markets where power demand and infrastructure readiness are converging.”

Scale, capital and a 25-year foundation

The first plant is the starting point, not the ceiling. Beyond the initial 50 MWe facility, future TAE fusion power plants are expected to range from 350 to 500 MWe, reflecting the company’s goal of delivering utility-scale fusion energy to the grid and to carbon-intensive industrial processes.

TAE arrives at this stage with a substantial technical foundation. The company has built and safely operated five fusion reactors over more than 25 years of research and development, holds over 1,600 granted patents, and employs more than 400 staff including 62 PhD holders. Prior private investors include Google, Chevron Technology Ventures, Goldman Sachs and Sumitomo Corporation of Americas, among others, who together helped TAE raise more than $1.3 billion before the TMTG transaction.

That financial foundation has now grown considerably. The all-stock merger with TMTG, announced on 18 December 2025 and valued at more than $6 billion, will see each company’s shareholders hold approximately 50% of the combined entity. TMTG has already transferred $200 million in cash to TAE, with a further $100 million available upon filing of a Form S-4 with the U.S. Securities and Exchange Commission. The transaction is expected to close in mid-2026, subject to shareholder and regulatory approvals. Upon closing, Binderbauer and TMTG’s Devin Nunes will serve as co-CEOs of the combined company, with Michael B. Schwab expected to chair a nine-member board.

For the fusion sector more broadly, TAE’s multi-state site evaluation process underscores how reactor economics and deployment logistics now weigh as heavily as plasma physics milestones. Industry analysts note that companies securing grid-ready sites early – with infrastructure and stakeholder alignment already in place – will hold a key advantage entering the 2030s.

Stay ahead in the fusion revolution explore more breakthroughs from leading innovators in clean energy technology.

TAE Technologies begins U.S. site selection for first 50 MWe fusion power plant targeted for early 2030s

What TAE Is evaluating

The leadership team on the ground

Scale, capital and a 25-year foundation

Share this:

TAE Technologies begins U.S. site selection for first 50 MWe fusion power plant targeted for early 2030s